BCAB

BioAtla Inc

May 18 • 04:00PM ET

3.92

-0.35 -8.20 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SABS IMNN BCTX BLRX HOTH

| Held by: VTI VXF BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-41.83	Insider Own	16.78%	Shs Outstand	1.66M	Perf Week	-13.27%
Market Cap	6.51M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.38M	Perf Month	-14.60%
Enterprise Value	10.64M	PEG	-	EPS next Q	-	Inst Own	12.66%	Short Float	10.67%	Perf Quarter	-44.48%
Income	-50.62M	P/S	3.25	EPS this Y	-	Inst Trans	-0.18%	Short Ratio	3.82	Perf Half Y	-88.12%
Sales	2.00M	P/B	-	EPS next Y	-	ROA	-216.05%	Short Interest	0.15M	Perf YTD	-86.19%
Book/sh	-22.48	P/C	3.32	EPS next 5Y	-	ROE	-813.88%	52W High	71.50 -94.52%	Perf Year	-80.41%
Cash/sh	1.18	P/FCF	-	EPS past 3/5Y	28.18% 0.99%	ROIC	-	52W Low	3.92 0.00%	Perf 3Y	-97.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 36.06%	Gross Margin	84.50%	Volatility	10.38% 11.99%	Perf 5Y	-99.83%
Dividend TTM	-	EV/Sales	5.32	EPS Y/Y TTM	31.28%	Oper. Margin	-2524.95%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.15	Sales Y/Y TTM	-81.82%	Profit Margin	-2530.85%	RSI (14)	36.34	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.15	EPS Q/Q	67.91%	SMA20	-14.44%	Beta	0.79	Target Price	52.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-34.21%	Rel Volume	0.96	Prev Close	4.27
Employees	41	LT Debt/Eq	-	Earnings	Mar 31 AMC	SMA200	-82.36%	Avg Volume	38.56K	Price	3.92
IPO	Dec 16, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	37,463	Change	-8.20%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)